88 / 89
88
systemic sclerosis. Clin Pharmacol Ther
1990;47:483-9.
136.
Duboc D, Kahan A, Maziere B, Loc'h C,
Crouzel C, Menkès CJ, et al. The effect of
nifedipine on myocardial perfusion and
metabolism in systemic sclerosis. A positron
emission tomographic study. Arthritis Rheum
1991;34:198-203.
137.
Vignaux O, Allanore Y, Meune C, Pascal O,
Duboc D, Weber S, et al. Evaluation of the
effect of nifedipine upon myocardial perfusion
and contractility using cardiac magnetic
resonance imaging and tissue Doppler
echocardiography in systemic sclerosis. Ann
Rheum Dis 2005;64:1268-73.
138.
Kahan A, Devaux JY, Amor B, Menkès CJ,
Weber S, Guérin F, et al. Pharmacodynamic
effect of nicardipine on left ventricular
function in systemic sclerosis. J Cardiovasc
Pharmacol 1990;15:249-53.
139.
Hegedüs I, Czirják L. Left ventricular wall
thickness and disease duration in systemic
sclerosis. Postgrad Med J 1993;69:285-90.
140.
Meune C, Allanore Y, Pascal O, Devaux JY,
Dessault O, Duboc D, et al. Myocardial
contractility is early affected in systemic
sclerosis: a tissue Doppler echocardiography
study. Eur J Echocardiogr 2005;6:351-7.
141.
Meune C, Avouac J, Wahbi K, Cabanes L,
Wipff J, Mouthon L, et al. Cardiac involvement
in systemic sclerosis assessed by tissue-